CABRIKAAN PRODUCTIONS LIMITED – Trademark Portfolio
Entity Type: 99
CABRIKAAN PRODUCTIONS LIMITED holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 32 (Light Beverages) across 2 Nice Classification classes. Currently, 3 trademarks are registered and 1 is pending. Notable registered marks include KAVA DAY, KAVA NIGHT, and KAKARIKI SUPER GREENS.
BDO WELLINGTON LIMITED,
Level 1, 50 Customhouse Quay Wellington6
Showing of trademarks Trademarks
Trademark Classifications
CABRIKAAN PRODUCTIONS LIMITED's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Frequently Asked Questions
How many trademarks does CABRIKAAN PRODUCTIONS LIMITED have?
CABRIKAAN PRODUCTIONS LIMITED has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 pending, 1 abandoned.
What trademark classes does CABRIKAAN PRODUCTIONS LIMITED file in?
CABRIKAAN PRODUCTIONS LIMITED files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 32 (Light Beverages). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are CABRIKAAN PRODUCTIONS LIMITED's most well-known trademarks?
CABRIKAAN PRODUCTIONS LIMITED's registered trademark portfolio includes well-known marks such as KAVA DAY, KAVA NIGHT, and KAKARIKI SUPER GREENS. These are among 3 currently registered trademarks in the portfolio.
What is CABRIKAAN PRODUCTIONS LIMITED's trademark registration success rate?
CABRIKAAN PRODUCTIONS LIMITED has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 1 application is pending review.